InnovAge downgraded by Piper Sandler with a new price target
$INNV
Medical/Nursing Services
Health Care
Piper Sandler downgraded InnovAge from Neutral to Underweight and set a new price target of $5.00 from $4.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
| 5/16/2022 | $6.00 → $5.00 | Outperform → Neutral | Robert W. Baird |
| 4/20/2022 | $4.00 → $5.00 | Neutral → Underweight | Piper Sandler |
| 1/10/2022 | $8.00 → $5.00 | Neutral | Citigroup |
| 12/28/2021 | $15.00 → $4.00 | Buy → Neutral | Goldman Sachs |
| 12/27/2021 | $22.00 → $6.50 | Overweight → Equal-Weight | Barclays |
| 12/23/2021 | $14.00 → $4.00 | Overweight → Neutral | Piper Sandler |
| 12/17/2021 | $10.00 | Neutral | JP Morgan |
InnovAge Holding (NASDAQ:INNV) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $193.073 million which beat the analyst consensus estimate of $188.246 million by 2.56 percent. This is a 11.90 percent increase over sales of $172.539 million the same period last year.
Gainers GeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings came out today. InnovAge Holding (NASDAQ:INNV) shares increased by 7.25% to $3.99. The market value of their outstanding shares is at $542.2 million. Mustang Bio (NASDAQ:MBIO) shares increased by 5.48% to $0.25. The market value of their outstanding shares is at $2.5 million. Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 5.23% to $0.79. The market value of their outstanding shares is at $38.1 million. Seelos Therapeutics (NASDAQ:SEEL) shares increased by 4.88% to $0.29. The market
SC 13G/A - InnovAge Holding Corp. (0001834376) (Subject)
DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as its new President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, effective November 4th. Mr. Scarbrough joins InnovAge's executive leadership team as Christine Bent steps down from the role of COO to explore new career opportunities. Scarbrough will also assume the role of President as the Company separates the positions of President and CEO to better enable exec
DENVER, May 20, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), welcomes John Koehn as its Senior Vice President of External Affairs as of May 13, 2024. John brings a wealth of experience in healthcare management and a proven track record of success in areas critical to InnovAge's mission and growth, including P&L and risk management, long-term care, provider relations, and business development. John has had exceptional success in fostering close relationships with key stakeholders to drive program manageme
DENVER, Aug. 14, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the appointment of Teresa Sparks to its Board of Directors, effective immediately. Sparks joins InnovAge's Board as Sean Traynor of Welsh, Carson, Anderson & Stowe steps down. The InnovAge team and Board thank Mr. Traynor for his service. "Teresa's diverse experience across multiple sectors, including in financial services, life sciences, specialty pharmacy, healthcare services, and technology, is a huge asset and co
10-Q - InnovAge Holding Corp. (0001834376) (Filer)
8-K - InnovAge Holding Corp. (0001834376) (Filer)
8-K - InnovAge Holding Corp. (0001834376) (Filer)
4 - InnovAge Holding Corp. (0001834376) (Issuer)
3 - InnovAge Holding Corp. (0001834376) (Issuer)
4 - InnovAge Holding Corp. (0001834376) (Issuer)
DENVER, Nov. 05, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal first quarter ended September 30, 2024. "Our first quarter results reflect our continued momentum and the execution of our strategy to deliver high quality care, while continuing to enhance our margins," said CEO Patrick Blair. "Our strategic initiatives are delivering measurable results, and we remain focused on operational excellence in our centers as we d
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2025 fiscal first quarter financial results on Tuesday, November 5, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be available via webca
DENVER, Aug. 27, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2024 fiscal fourth quarter and full year financial results on Tuesday, September 10, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be avai
KeyBanc Capital Markets initiated coverage of InnovAge with a rating of Sector Weight
Robert W. Baird downgraded InnovAge from Outperform to Neutral and set a new price target of $5.00 from $6.00 previously
Piper Sandler downgraded InnovAge from Neutral to Underweight and set a new price target of $5.00 from $4.00 previously
DENVER, Nov. 05, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal first quarter ended September 30, 2024. "Our first quarter results reflect our continued momentum and the execution of our strategy to deliver high quality care, while continuing to enhance our margins," said CEO Patrick Blair. "Our strategic initiatives are delivering measurable results, and we remain focused on operational excellence in our centers as we d
DENVER, Nov. 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), appoints Michael Scarbrough as its new President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services, effective November 4th. Mr. Scarbrough joins InnovAge's executive leadership team as Christine Bent steps down from the role of COO to explore new career opportunities. Scarbrough will also assume the role of President as the Company separates the positions of President and CEO to better enable exec
DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced it will release its 2025 fiscal first quarter financial results on Tuesday, November 5, 2024, after market close. In conjunction, the Company will host a conference call to review the results at 5 p.m. E.T. Conference Call DetailsA live audio webcast of the call will be available on the Company's website, https://investor.innovage.com/. A replay of the call will be available via webca